Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

REPAIR Is Trying To Fix The Antibiotic Gap Left By Industry

Aleks Engel of Novo Holdings — Novo Holdings Partner Aleks Engel

Related Content

Brits Lead Charge In Global Battle Against Antimicrobial Resistant Superbugs

Jun 20 2018

US FDA Joins Chorus Of Concerns About Results Of GAIN Act

Feb 05 2018

Anti-Infective R&D Ecosystem Getting Healthier, But Trials Remain

Nov 16 2015

EU's "Horizon 2020" to fund innovative drug/diagnostic R&D and boost life sciences industry

Nov 22 2013

Antibiotic Incentives: Pfizer’s Read Touts Exclusivity Voucher

Mar 29 2017

Melinta Expands Portfolio, TMC Narrows Focus To LDL Reduction With Anti-Infective Deal

Nov 29 2017

Melinta: A Pure-Play Antibiotics Specialist Rises

Jan 23 2018

Finance Watch: Three New Funds, Including Former Amgen R&D Head Harper's Next Venture

Sep 07 2018

ABAC Chief Calls For Better Antibiotic R&D Incentives In Europe

Feb 26 2018

Novo $165m Superbug Fund is Fillip For Antibiotic Start-Ups

Feb 28 2018

Alarm As Novartis Exits Antibiotics Space

Jul 12 2018

Related Companies

Polyphor AG

ABAC Therapeutics

Merck & Co., Inc.

Roche Holding AG

Novartis AG

Allergan plc

Sanofi

Achaogen, Inc.

The Medicines Company

Melinta Therapeutics, Inc.

Additional Topics

Financing Commercial Business Strategies Biologics Research & Development Infectious Diseases BioPharmaceutical

More from Anti-infective

More from Therapeutic Category

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window